Evidence map›Paper›PMID 20565573›Full record

ArticleJournal of viral hepatitis2011

Evidence for separation of HCV subtype 1a into two distinct clades.

B E Pickett, R Striker, E J Lefkowitz

Abstract read
In one paragraph

Article in Journal of viral hepatitis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

B E PickettDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
R Striker
E J Lefkowitz

Funding

INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
BASIC MECHANISMS IN VIROLOGYT32AI007150 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PREVELIGE, PETER E. · 1985 to 2007
$1.7M
Hepatitis C Virus Quasispecies in the Resistance to Antiviral TherapyR01DK080711 · NIDDK · SAINT LOUIS UNIVERSITY · PI FAN, XIAOFENG · 2008 to 2012
$1.5M
Genotyping and Phenotyping the Hepatitis C Drug Target NS5AI01CX000117 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI STRIKER, ROBERT T · 2009 to 2011
–
CSRD VA I01 CX000117NCRR NIH HHS 1UL1RR025011NCRR NIH HHS UL1 RR025011NIAID NIH HHS 5 T32 AI007150-29NIAID NIH HHS HHSN266200400036CNIAID NIH HHS T32 AI007150NIDDK NIH HHS R01 DK080711
6 · The paper itself

Abstract

The nucleotide sequence diversity present among hepatitis C virus (HCV) isolates allows rapid adjustment to exterior forces including host immunity and drug therapy. This viral response reflects a combination of a high rate of replication together with an error-prone RNA-dependent RNA polymerase, providing for the selection and proliferation of the viruses with the highest fitness. We examined HCV subtype 1a whole-genome sequences to identify positions contributing to genotypic and phenotypic diversity. Phylogenetic tree reconstructions showed two distinct clades existing within the 1a subtype with each clade having a star-like tree topology and lacking definite correlation between time or place of isolation and phylogeny. Identification of significant phylogenetically informative sites at the nucleotide level revealed positions not only contributing to clade differentiation, but which are located at or proximal to codons associated with resistance to protease inhibitors (NS3 Q41) or polymerase inhibitors (NS5B S368). Synonymous/nonsynonymous substitution mutation analyses revealed that the majority of nucleotide mutations yielded synonymous amino acids, indicating the presence of purifying selection pressure across the polyprotein with pockets of positive selection also being detected. Despite evidence for divergence at several loci, certain 1a characteristics were preserved including the length of the alternative reading frame/F protein (ARF/F) gene, and a subtype 1a-specific phosphorylation site in NS5A (S349). Our analysis suggests that there may be strain-specific differences in the development of antiviral resistance to viruses infecting patients who are dependent on the genetic variation separating these two clades.

Indexed as

Drug Resistance, ViralGenome, ViralAntiviral AgentsBase SequenceCodonDEAD-box RNA HelicasesGenotypeHepacivirusHumansMutationNucleoside-TriphosphatasePhylogenyProtease InhibitorsSelection, GeneticSequence AlignmentSerine EndopeptidasesAntiviral AgentsCodonDEAD-box RNA Helicaseshepatitis C protein F, Hepatitis C virusNS3 protein, hepatitis C virusNucleoside-TriphosphataseProtease InhibitorsSerine EndopeptidasesViral Core ProteinsViral Nonstructural ProteinsViral Proteases

Identifiers

PMID20565573
PMCPMC2964416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.